-
- Centrífugas de bancada
- Centrífugas de piso
- Centrífugas refrigeradas
- Microcentrífugas
- Centrífugas multiúso
- Centrífugas de alta velocidade
- Ultracentrífugas
- Concentrator
- High-Speed and Ultracentrifuge Consumables
- Tubos de centrífuga
- Placas de centrífuga
- Gerenciamento de dispositivo
- Gerenciamento de amostras e informação
-
- Pipetagem manual & dispensação
- Pipetas mecânicas
- Pipetas eletrônicas
- Pipetas multicanal
- Pipetas de deslocamento positivo e dispensadores
- Sistema automatizado de Pipetagem
- Dispensadores de bancada
- Controladores de pipeta
- Ponteiras de pipeta
- Consumíveis de automação
- Acessórios para pipetas e dispensadores
- Acessórios de automação
- Serviços para pipetas e dispensadores
Read more
Read less
CAR-T Cells: Breakthroughs in Cancer and Auto-Immune Therapies
Read more
Read less
CAR-T Cell Development – The Future of Fighting Cancer
CAR-T cells, genetically engineered and equipped with specific receptors to target and combat cancer cells, are primarily divided into two categories: autologous and allogenic CAR-T cells. Hereby, autologous CAR-T cells derive from the patient’s own white blood cells and are reintroduced after modification, whereas allogenic CAR-T cells are designed as off-the-shelf solutions for use in different patients. However, both approaches have their challenges. The manufacturing process for autologous CAR-T cells is complex and costly, as each patient’s cells must be individually processed. Allogeneic CAR-T cells, on the other hand, currently do not have the same safety profile, necessitating further research to address these issues.